Cargando…

Dehydroepiandrosterone supplementation in women undergoing assisted reproductive technology with poor ovarian response. A prospective case-control study

OBJECTIVE: The effects of dehydroepiandrosterone (DHEA) supplementation in Saudi Arabian women with poor ovarian response (POR) is presently unknown. The present study aimed to assess the benefits of DHEA supplementation in women undergoing in vitro fertilization (IVF) or intracytoplasmic sperm inje...

Descripción completa

Detalles Bibliográficos
Autor principal:	Al-Turki, Haifa A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Research Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6011324/ https://www.ncbi.nlm.nih.gov/pubmed/28758852 http://dx.doi.org/10.1177/0300060517720005

Ejemplares similares

The impact of dehydroepiandrosterone in poor ovarian responders on assisted reproduction technology treatment
por: Monteiro, Cecilia de Souza, et al.
Publicado: (2019)

Efficacy of dehydroepiandrosterone priming in women with poor ovarian response undergoing IVF/ICSI: a meta-analysis
por: Zhang, Jie, et al.
Publicado: (2023)

The effect of dehydroepiandrosterone supplementation on ovarian response is associated with androgen receptor in diminished ovarian reserve women
por: Hu, Qiaofei, et al.
Publicado: (2017)

Dehydroepiandrosterone supplementation and the impact of follicular fluid metabolome and cytokinome profiles in poor ovarian responders
por: Viardot-Foucault, Veronique, et al.
Publicado: (2023)

Dehydroepiandrosterone (DHEA) supplementation in diminished ovarian reserve (DOR)
por: Gleicher, Norbert, et al.
Publicado: (2011)

Effect of Dehydroepiandrosterone Administration in Patients with Poor Ovarian Response According to the Bologna Criteria
por: Xu, Bei, et al.
Publicado: (2014)

Dehydroepiandrosterone enhances decidualization in women of advanced reproductive age
por: Gibson, Douglas A., et al.
Publicado: (2018)

Novel dehydroepiandrosterone troche supplementation improves the serum androgen profile of women undergoing in vitro fertilization
por: Keane, Kevin N, et al.
Publicado: (2015)

Urinary Versus Recombinant Gonadotropins for Ovarian Stimulation in Women Undergoing Treatment with Assisted Reproductive Technology
por: Patki, Ameet, et al.
Publicado: (2018)

Hysterosalpingogram findings among subfertile women undergoing assisted reproductive technology
por: Al-Jaroudi, Dania, et al.
Publicado: (2018)

Efficacy of dehydroepiandrosterone to improve ovarian response in women with diminished ovarian reserve: a meta-analysis
por: Narkwichean, Amarin, et al.
Publicado: (2013)

The combination of dehydroepiandrosterone, transdermal testosterone, and growth hormone as an adjuvant therapy in assisted reproductive technology cycles in patients aged below 40 years with diminished ovarian reserve
por: Haydardedeoğlu, Bülent, et al.
Publicado: (2015)

Dehydroepiandrosterone (DHEA) supplementation improves in vitro fertilization outcomes of poor ovarian responders, especially in women with low serum concentration of DHEA-S: a retrospective cohort study
por: Chern, Chyi-Uei, et al.
Publicado: (2018)

Miscarriage rates after dehydroepiandrosterone (DHEA) supplementation in women with diminished ovarian reserve: a case control study
por: Gleicher, Norbert, et al.
Publicado: (2009)

Dehydroepiandrosterone Ameliorates Abnormal Mitochondrial Dynamics and Mitophagy of Cumulus Cells in Poor Ovarian Responders
por: Li, Chia-Jung, et al.
Publicado: (2018)

Association between Leukemia Inhibitory Factor Gene Polymorphism and Clinical Outcomes among Young Women with Poor Ovarian Response to Assisted Reproductive Technology
por: Liu, Yung-Liang, et al.
Publicado: (2023)

Dehydroepiandrosterone plus climen supplementation shows better effects than dehydroepiandrosterone alone on infertility patients with diminished ovarian reserve of low-FSH level undergoing in-vitro fertilization cycles: a randomized controlled trial
por: Zhang, Huanhuan, et al.
Publicado: (2016)

Impact of dehydroepiandrosterone on clinical outcome in poor responders: A pilot study in women undergoing in vitro fertilization, using bologna criteria
por: Jirge, Padma Rekha, et al.
Publicado: (2014)

The Application of Dehydroepiandrosterone on Improving Mitochondrial Function and Reducing Apoptosis of Cumulus Cells in Poor Ovarian Responders
por: Lin, Li-Te, et al.
Publicado: (2017)

Ways of coping among women with infertility undergoing assisted reproductive technologies in Ghana
por: Kyei, Josephine Mpomaa, et al.
Publicado: (2022)

The effect of Myo-inositol on fertility rates in poor ovarian responder in women undergoing assisted reproductive technique: a randomized clinical trial
por: Mohammadi, Sahar, et al.
Publicado: (2021)

5-Methyltetrahydrofolate and Vitamin B12 Supplementation Is Associated with Clinical Pregnancy and Live Birth in Women Undergoing Assisted Reproductive Technology
por: Cirillo, Michela, et al.
Publicado: (2021)

Dehydroepiandrosterone Supplementation Improves the Outcomes of in vitro Fertilization Cycles in Older Patients With Diminished Ovarian Reserve
por: Chen, San-Nung, et al.
Publicado: (2019)

Granulocyte Macrophage Colony Stimulating Factor Supplementation in Culture Media for Subfertile Women Undergoing Assisted Reproduction Technologies: A Systematic Review
por: Siristatidis, Charalampos, et al.
Publicado: (2013)

Serum and follicular fluid organochlorine concentrations among women undergoing assisted reproduction technologies
por: Meeker, John D, et al.
Publicado: (2009)

Experiences of women undergoing assisted reproductive technology in Ghana: A qualitative analysis of their experiences
por: Anaman-Torgbor, Judith A., et al.
Publicado: (2021)

Digital integrated dramatherapy: A feasibility study in women undergoing assisted reproductive technology
por: Cercato, Maria Cecilia, et al.
Publicado: (2022)

The effect of metabolic syndrome on controlled ovarian stimulation outcome in infertile women with polycystic ovary syndrome undergoing assisted reproductive technology cycles
por: Moini, Ashraf, et al.
Publicado: (2022)

Importance of Melatonin in Assisted Reproductive Technology and Ovarian Aging
por: Tamura, Hiroshi, et al.
Publicado: (2020)

Efficacy and Safety of Pergoveris in Assisted Reproductive Technology—ESPART: rationale and design of a randomised controlled trial in poor ovarian responders undergoing IVF/ICSI treatment
por: Humaidan, P, et al.
Publicado: (2015)

High serum Antimullerian hormone levels are associated with lower live birth rates in women with polycystic ovarian syndrome undergoing assisted reproductive technology
por: Tal, Reshef, et al.
Publicado: (2020)

Status of racial disparities between black and white women undergoing assisted reproductive technology in the US
por: Seifer, D. B., et al.
Publicado: (2020)

Extreme Desire for Motherhood: Analysis of Narratives From Women Undergoing Assisted Reproductive Technology (ART)
por: Langher, Viviana, et al.
Publicado: (2019)

Reproductive outcomes in women and men conceived by assisted reproductive technologies in Norway: prospective registry based study
por: Carlsen, Ellen Øen, et al.
Publicado: (2023)

Dehydroepiandrosterone (DHEA) Supplementation in Rheumatic Diseases: A Systematic Review
por: Skare, Thelma L., et al.
Publicado: (2023)

Reproductive outcomes in women and men conceived by assisted reproductive technologies
por: Doulgeraki, Triada, et al.
Publicado: (2023)

Dehydroepiandrosterone as an adjunct to gonadotropins in infertile Indian women with premature ovarian aging: A pilot study
por: Malik, Nisha, et al.
Publicado: (2015)

Safety of Ovaleap® (Follitropin Alfa) in Infertile Women Undergoing Superovulation for Assisted Reproductive Technologies: A Multinational Comparative, Prospective Cohort Study
por: Kaplan, Sigal, et al.
Publicado: (2021)

Comparison of ovarian responsiveness tests with outcome of assisted reproductive technology – a retrospective analysis
por: Selcuk, Selcuk, et al.
Publicado: (2016)

Ozone sauna therapy and pulsed electromagnetic field therapy could potentially improve outcome in women with diminished ovarian reserve undergoing assisted reproductive technology
por: Dias, Ashini R., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_up9dj598jcfnfgdenu4b3r4kve